July 18, 2013

OPPORTUNITY OVERVIEW
Financing: $1.6 million for Commercial Demonstration
The statements herein are based on information that we believe to be reliable, but we cannot represent that they are complete or accurate. This
document is for information purposes only and does not constitute an offer to sell or a solicitation to buy the securities referred to herein. All
dollar amounts are approximate unless otherwise specified.

Converted Carbon Technologies Corp.

Converted Carbon Technologies Corp. (CCT), based in Toronto, Ontario, and founded in 2008, has developed a
scalable BioSilo system for the production of low cost ultra-pure algae biomass and Omega-3. These products
target the food additive and functional ingredient market where algae based products have traction, providing
nutrients to foods, beverages and supplements.
The company will generate revenue by supplying powdered algae biomass, initially chlorella powder and Omega-3
oil that can be used as nutrient rich ingredients for its customers. The average prices are $46.80/kg for chlorella
powder and $87.85/kg for Omega-3 oils with manufacturing costs of $4.70/kg and $39.00/kg, respectively. The
global consulting and research firm Frost & Sullivan forecasts a growth in the North American nutritional and
functional ingredient market from $2.2 billion (2011) to $3.29 billion in 2018; a CAGR of approximately 6%. Omega3 alone is forecasted to reach $2.8 billion in revenues by 2015 where algae has a CAGR of currently 12%.
CCT has two competitive advantages. First, is the degree to which the BioSilo has been engineered to allow
extensive controls of the growth environment, or the perfect pond. This allows CCT to vary the humidity, CO2
level, temperature, and algae species used in order to generate optimal, highly efficient yields resulting in low
manufactured costs. Secondly, the closed and tightly controlled process environment produces ultra pure algae
biomass and Omega-3 oil, avoiding further processing costs. CCTs system is unique and combines features of both
pond and tube systems. It is also scalable.
Having begun research and system design over 5 years ago, and having partnered with sector professionals and
algae experts at the University of Waterloo, CCT brings deep market knowledge and strong relationships to its new
project development business. BioSilo is undergoing IP protection. Both chlorella powder and algae-derived
Omega-3 oil are approved for human consumption with widely demonstrated health benefits.
CCT is raising $1,600,000 for commercial demonstration and subsequently an additional $2,500,000 for
commercial rollout. CCT anticipates a public company transaction in approximately 12 months from the date of
closing of this offering. The business is expected to generate sufficient cash from operations to fund its own
growth, except for small short term working capital loan facilities. CCT will build and operate multiple commercial
BioSilo systems as a leading supplier of algae biomass and Omega-3 oils for the functional additive and
supplement markets. CCT will target large food manufacturers who incorporate functional food additives in their
products as well as supplement retailers.
To date, CCT has seen $2,515,625 in funding ($510,000 in cash, $250,000 from the Ontario Power Authority and
$1,755,625 in founder contributions in kind).

July 18, 2013

OPPORTUNITY HIGHLIGHTS
Year 1
000s

Year 2
000s

Year 3
000s

Year 4
000s

Year 5
000s

Revenue

$130

$ 5,482

$ 14,161

$ 34,288

$ 56,068

EBITDA

-$ 1,241

$ 1,252

$ 5,038

$ 16,527

$ 29,615

$ 1,600
Private Placement
$ 1,400

$ 1,100

Management team with a track record The management team is experienced in working together,
combining sales and marketing, engineering and financial skills and demonstrating a proven track record.
Paul Ramsay and Richard Rusiniak seeded, took public and grew Cymat Technologies, building an enterprise
value to $150,000,000 before exiting in 2002 and monetizing their shares successfully. They have focused
their time and capital on CCT since 2008.

Sales pipe line in place CCT has had dialogue with and shared algae biomass nutrient values with several
companies that expressed interest in the nutrient attributes of Chlorella and Omega-3s. CCT also had
meetings with companies such as Univar Canada, Parmalat Canada and Adeeva. These respective companies
are receptive to testing CCTs products from its commercial facility.

Differentiating technology CCTs BioSilo exceeds the purity and efficiency of competing technologies by
combining the best features of open pond and closed algae production systems. The system is scalable, has
low energy requirements and incorporates a unique CO delivery system. The BioSilo has been engineered
to provide maximum control over process conditions, creating the perfect pond with optimal growth
conditions increasing yield while producing ultra high quality for a wide variety of algae species.

Rapid growth, high margin and low capital costs CCTs business model has the unique combination of high
gross margin and relatively low capital costs in a growing market. Upon completion of funding for commercial
rollout, this facilitates rapid growth potential.

CONTACT
Paul Ramsay
President
Converted Carbon Technologies Corp.
416-704-3040
ramsay@convertedcarbon.com

Sandra Elsley
VP Corporate Communications
Converted Carbon Technologies Corp.
905-348-8887
elsley@convertedcarbon.com

July 18, 2013